Different light therapies have long been for decades used successfully in the treatment of inflammatory and hyperproliferative skin diseases, yet the Rhinolight phototherapy is the first method capable of treating allergic rhinitis, one of the inflammatory diseases of the nasal mucosa. In Hungary, a research group at the Department of Dermatology and Allergology and at the Department of Optics and Quantum Electronics of the Szeged University, headed by Prof. Lajos Kemény, developed a method, first in the world, based on light therapy which can be used successfully to treat patients suffering from allergic rhinitis.
The intranasal Rhinolight phototherapy is for the treatment of allergic rhinitis regardless of what the allergen-inducing the symptom is. The intranasal Rhinolight phototherapy can be given to the following groups of patients suffering from allergic rhinitis diagnosed by and ENT or allergologist specialist:
- Patients, whose symptoms cannot be adequately controlled by using combined oral antihistamine and intranasal drug therapy.
- Patients, for whom ordinary drug therapy is contraindicated, triggers unwanted effects, or may result medicine interaction.
- Patients, who are unwilling to undertake long-term medicine therapy.
The intranasal Rhinolight phototherapy is contraindicated:
- For patients, for whom the treatment is technically impossible to administer in the prescribed dose due to an anatomical disorder (e.g. septum deviation)
- For patients, who, besides allergic rhinitis, also suffer from other active inflammatory diseases of the nasal cavity (e.g. bacterial or viral infection)
- For patients who suffer from other serious illnesses (e.g. nasopharyngeal tumour). In order to exclude these possibilities, an otorhinolaryngological examination is advised prior to the treatment.
- For patients, in whom intense dryness of the nasal mucosa, crusting and perhaps mild blood leaking might occur as a side effect. In order to prevent this, vitamin A oil can be applied. Rhinolight treatments can only be continued after mucous membrane complaints have disappeared.
- For patients, at whom earlier any chronic mutation had formed on the skin due to the effect of light.
